- Represented MGC Diagnostics Corporation (“MGCD”) on its sale to Altus Capital Partners, Inc. (“Altus”).
- MGC Diagnostics is a leading global medical technology company dedicated to cardiorespiratory health solutions.
- MGC Diagnostics was exploring strategic alternatives to support the next phase of its growth strategy, while also providing shareholders immediate liquidity.
Drivers of Interest
- Differentiated Equipment/Technology and Recurring Revenue and Services.
- Highly Experienced Management Team With Impressive Track Record.
- Convergence of Multiple Industry Growth Drivers.
- Unique Competitive Position.
- Substantial Growth Opportunity in Upstream Cardiorespiratory Market.
- Credible and Proven Sales and Marketing Initiatives Driving Growth.
- Best-of-Breed Diagnostic Software.